A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer. uri icon

authors

  • Krop, Ian
  • Morris, Patrick G
  • Schwartzberg, Lee
  • Chan, Stephen
  • Gucalp, Ayca
  • Biganzoli, Laura
  • Steinberg, Joyce
  • Sica, Lorenzo
  • Trudeau, Maureen
  • Markova, Denka
  • Tarazi, Jamal
  • Abramson, Vandana
  • Zhu, Zhou
  • O'Brien, Thomas
  • Kelly, Catherine M
  • Winer, Eric
  • Yardley, Denise A
  • Colleoni, Marco
  • Traina, Tiffany
  • Holmes, Frankie
  • Garcia-Estevez, Laura
  • Hart, Lowell
  • Awada, Ahmad
  • Zamagni, Claudio

publication date

  • January 1, 2020